PL1845780T3 - Zastosowanie pochodnych metylofenidatu - Google Patents

Zastosowanie pochodnych metylofenidatu

Info

Publication number: PL1845780T3
Authority: PL; Poland
Prior art keywords: sup; methylphenidate derivatives; methylphenidate; derivatives; prodrugs
Prior art date: 2005-01-20

Application number

PL06719144T

Other languages

English (en)

Inventor

David Bar-Or

Isaac Melamed

Original Assignee

Ampio Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-20

Filing date

2006-01-20

Publication date

2011-12-30

2006-01-20 Application filed by Ampio Pharmaceuticals Inc filed Critical Ampio Pharmaceuticals Inc

2011-12-30 Publication of PL1845780T3 publication Critical patent/PL1845780T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Oncology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)

PL06719144T 2005-01-20 2006-01-20 Zastosowanie pochodnych metylofenidatu PL1845780T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US64577805P	2005-01-20	2005-01-20
PCT/US2006/002181 WO2006078984A2 (en)	2005-01-20	2006-01-20	Uses of methylphenidate derivatives
EP06719144A EP1845780B1 (en)	2005-01-20	2006-01-20	Uses of methylphenidate derivatives

Publications (1)

Publication Number	Publication Date
PL1845780T3 true PL1845780T3 (pl)	2011-12-30

Family

ID=36692960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06719144T PL1845780T3 (pl)	2005-01-20	2006-01-20	Zastosowanie pochodnych metylofenidatu

Country Status (10)

Country	Link
US (1)	US20060183773A1 (pl)
EP (1)	EP1845780B1 (pl)
JP (3)	JP5274844B2 (pl)
CN (1)	CN101123965B (pl)
AT (1)	ATE517623T1 (pl)
ES (1)	ES2372004T3 (pl)
HR (1)	HRP20110779T1 (pl)
PL (1)	PL1845780T3 (pl)
SI (1)	SI1845780T1 (pl)
WO (1)	WO2006078984A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006078887A2 (en)	2005-01-20	2006-07-27	Institute For Molecular Medicine, Inc.	Methylphenidate derivatives and uses of them
US8217047B2 (en) *	2008-05-27	2012-07-10	Dmi Acquisition Corp.	Therapeutic methods and compounds
CN102134208B (zh) *	2010-01-27	2014-05-14	爱斯特（成都）医药技术有限公司	[r,r]-哌甲酯中间体及其类似物以及它们的合成与应用
US10085414B2 (en) *	2011-05-19	2018-10-02	Gilrose Pharmaceuticals, Llc	Pre-frontal cortex processing disorder speech, gait and limb impairments treatment
SG10201408115SA (en) *	2014-12-05	2016-07-28	Chakra Biotech Pte Ltd	Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
JPWO2016110998A1 (ja) *	2015-01-09	2017-07-06	三菱電機株式会社	室外機及び空気調和装置
JP7199656B2 (ja) *	2018-12-07	2023-01-06	日本たばこ産業株式会社	注意欠如・多動症又は注意欠如・多動性障害の評価方法及び評価を補助するための方法、並びに注意欠如・多動症又は注意欠如・多動性障害を評価するためのデータ取得方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2507631A (en) *	1944-01-19	1950-05-16	Ciba Pharm Prod Inc	Pyridine and piperidine compounds and process of making same
US2957880A (en) *	1953-12-23	1960-10-25	Ciba Pharm Prod Inc	Process for the conversion of stereoisomers
US5407926A (en) *	1987-12-29	1995-04-18	Alcon Laboratories, Inc.	Ophthalmic composition
WO1995026734A1 (en) *	1994-04-04	1995-10-12	Freeman William R	Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5658955A (en) *	1994-11-01	1997-08-19	Hitzig; Pietr	Combined use of dopamine and serotonin agonists in the treatment of immune disorders
CA2222713C (en) *	1995-07-14	2003-04-22	Andrew John Mcglashan Richards	Composition comprising d-threo-methylphenidate and another drug
US5908850A (en) *	1995-12-04	1999-06-01	Celgene Corporation	Method of treating attention deficit disorders with d-threo methylphenidate
US5922736A (en) *	1995-12-04	1999-07-13	Celegene Corporation	Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5859249A (en) *	1997-02-19	1999-01-12	Takasago International Corporation	2-phenyl-2-(2'-piperidinylidene)acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2-(2'-piperidinyl)acetate derivative by asymmetrically hydrogenating the same
US6210705B1 (en) *	1997-12-15	2001-04-03	Noven Pharmaceuticals, Nc.	Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
US6395752B1 (en) *	1999-03-04	2002-05-28	Pharmaquest Limited	Method of treating depression using 1-threo-methylphenidate
US6127385A (en) *	1999-03-04	2000-10-03	Pharmaquest Limited	Method of treating depression using l-threo-methylphenidate
US6025502A (en) *	1999-03-19	2000-02-15	The Trustees Of The University Of Pennsylvania	Enantopselective synthesis of methyl phenidate
DE19927080A1 (de) *	1999-06-15	2000-12-21	Zahnradfabrik Friedrichshafen	Zahnradlagerung in Getrieben
US20020132793A1 (en) *	2000-08-28	2002-09-19	Mel Epstein	Use of methylphenidate compounds to enhance memory
US20050101582A1 (en) *	2003-11-12	2005-05-12	Allergan, Inc.	Compositions and methods for treating a posterior segment of an eye
US20050192290A1 (en) *	2004-01-13	2005-09-01	Isaac Melamed	Treatment of behavioral disorders
WO2006078887A2 (en) *	2005-01-20	2006-07-27	Institute For Molecular Medicine, Inc.	Methylphenidate derivatives and uses of them

2006
- 2006-01-20 CN CN2006800055421A patent/CN101123965B/zh not_active Expired - Fee Related
- 2006-01-20 ES ES06719144T patent/ES2372004T3/es active Active
- 2006-01-20 SI SI200631125T patent/SI1845780T1/sl unknown
- 2006-01-20 WO PCT/US2006/002181 patent/WO2006078984A2/en active Application Filing
- 2006-01-20 JP JP2007552311A patent/JP5274844B2/ja not_active Expired - Fee Related
- 2006-01-20 EP EP06719144A patent/EP1845780B1/en active Active
- 2006-01-20 US US11/336,436 patent/US20060183773A1/en not_active Abandoned
- 2006-01-20 AT AT06719144T patent/ATE517623T1/de not_active IP Right Cessation
- 2006-01-20 PL PL06719144T patent/PL1845780T3/pl unknown
2011
- 2011-10-26 HR HR20110779T patent/HRP20110779T1/hr unknown
2013
- 2013-03-11 JP JP2013048099A patent/JP5681226B2/ja not_active Expired - Fee Related
2014
- 2014-10-08 JP JP2014207423A patent/JP2015003931A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
US20060183773A1 (en)	2006-08-17
JP2013199478A (ja)	2013-10-03
JP2015003931A (ja)	2015-01-08
ATE517623T1 (de)	2011-08-15
EP1845780B1 (en)	2011-07-27
CN101123965B (zh)	2012-08-22
JP2008528505A (ja)	2008-07-31
ES2372004T3 (es)	2012-01-12
WO2006078984A2 (en)	2006-07-27
EP1845780A2 (en)	2007-10-24
CN101123965A (zh)	2008-02-13
WO2006078984A3 (en)	2006-11-09
SI1845780T1 (sl)	2012-01-31
JP5274844B2 (ja)	2013-08-28
HRP20110779T1 (hr)	2011-12-31
JP5681226B2 (ja)	2015-03-04
EP1845780A4 (en)	2009-04-01

Publication	Publication Date	Title
UA94833C2 (en)	2011-06-10	Substituted bicyclolactams
MX2010003155A (es)	2010-04-01	Derivados de ciclopropil aril amida y uso de los mismos.
TW200745028A (en)	2007-12-16	Novel sulphonylpyrroles
MX2010003156A (es)	2010-04-01	Derivados de aril amida substituida con tetrazol y usos de los mismos.
PT1940839E (pt)	2013-10-10	Inibidores de piridopirimidinona pi3k alfa
TN2011000279A1 (en)	2012-12-17	Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
WO2007117465A3 (en)	2008-08-28	Indazole compounds
MX2009009774A (es)	2009-09-23	Derivados de quinolina como fungicidas.
TW200745027A (en)	2007-12-16	Novel sulphonylpyrroles
HK1119699A1 (en)	2009-03-13	Pyridopyrimidinone inhibitors of pi3kalpha
EA200901609A1 (ru)	2010-06-30	Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
MY151986A (en)	2014-07-31	Adamantyl diamide derivatives and uses of same
WO2007084728A3 (en)	2008-01-17	2-imino-benzimidazoles
TNSN08191A1 (en)	2009-10-30	Kinase inhibitors
WO2009024342A3 (en)	2009-04-23	Novel microbiocides
TW200612958A (en)	2006-05-01	Substituted imidazole derivatives
MX2009007713A (es)	2009-07-29	Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
DE602004009200D1 (de)	2007-11-08	Tetrahydrochinazolinderivate als cfr-antagonisten
ATE449776T1 (de)	2009-12-15	Pyrroloä2,3-cüpyridinderivate
WO2008151828A8 (en)	2010-01-07	Novel microbiocides
EA200801366A1 (ru)	2008-10-30	Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
PL1845780T3 (pl)	2011-12-30	Zastosowanie pochodnych metylofenidatu
UA86119C2 (ru)	2009-03-25	Амидные пролекарства гемцитабина, их композиции и применение
MY138466A (en)	2009-06-30	Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MX2009009490A (es)	2010-02-17	Profarmacos novedosos.